{"id":"vehicle-gel-bid","safety":{"commonSideEffects":[{"rate":"null","effect":"Eye irritation"}]},"_chembl":{"chemblId":"CHEMBL2108661","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"It works by creating a physical barrier on the surface of the eye to prevent dryness and irritation. This helps to maintain the health and comfort of the eyes.","oneSentence":"Vehicle Gel is a topical ophthalmic gel used to lubricate and protect the eyes.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:54:44.887Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Dry eye syndrome"},{"name":"Blepharitis"}]},"trialDetails":[{"nctId":"NCT06504160","phase":"PHASE1","title":"Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2025-04-10","conditions":"Atopic Dermatitis","enrollment":86},{"nctId":"NCT06050122","phase":"PHASE3","title":"Efficacy and Safety of Patidegib Gel 2% for Preventing Basal Cell Carcinomas on the Face of Adults With Gorlin Syndrome","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sol-Gel Technologies, Ltd.","startDate":"2024-03-17","conditions":"Gorlin Syndrome","enrollment":140},{"nctId":"NCT05240300","phase":"PHASE1, PHASE2","title":"A Study of Topical BX005-A in Subjects With Moderate to Severe Atopic Dermatitis","status":"WITHDRAWN","sponsor":"BiomX, Inc.","startDate":"2022-05","conditions":"Atopic Dermatitis","enrollment":""},{"nctId":"NCT06154200","phase":"PHASE2","title":"Eyelid Androgen Treatment in Dry Eye","status":"COMPLETED","sponsor":"Southern California College of Optometry at Marshall B. Ketchum University","startDate":"2023-04-02","conditions":"Aqueous Tear Deficiency, Meibomian Gland Dysfunction of Bilateral Eyes (Disorder)","enrollment":24},{"nctId":"NCT06587685","phase":"PHASE3","title":"A Study to Assess the Efficacy and Safety of PG-011 Gel in Adolescents and Adults With Atopic Dermatitis","status":"RECRUITING","sponsor":"Prime Gene Therapeutics Co., Ltd.","startDate":"2024-03-15","conditions":"Atopic Dermatitis","enrollment":472},{"nctId":"NCT05870865","phase":"PHASE2","title":"A Study to Evaluate the Anti-pruritic Effectiveness of ASN008 in Adults With Mild to Moderate Atopic Dermatitis","status":"COMPLETED","sponsor":"Formation Bio, Inc.","startDate":"2023-05-03","conditions":"Dermatitis, Atopic, Pruritus","enrollment":144},{"nctId":"NCT03990051","phase":"PHASE2","title":"Treatment Safety and Efficacy of Pro-ocular™ 1% for Chronic Ocular Graft Following Allogeneic HSCT.","status":"COMPLETED","sponsor":"Glia, LLC","startDate":"2019-10-17","conditions":"Chronic Ocular Graft-versus-host Disease","enrollment":33},{"nctId":"NCT06945393","phase":"","title":"ANTIPIGMENTING OR DEPIMENTING EFFICACY UNDER PART OF VISIBLE LIGHT","status":"COMPLETED","sponsor":"L'Oreal","startDate":"2021-10-21","conditions":"Visible Light Exposure on Healthy Back Skin","enrollment":30},{"nctId":"NCT06380907","phase":"PHASE2","title":"A Phase 2 Study of ZL-1102 in Patients With Chronic Plaque Psoriasis","status":"RECRUITING","sponsor":"Zai Lab (Hong Kong), Ltd.","startDate":"2024-05-22","conditions":"Plaque Psoriasis","enrollment":250},{"nctId":"NCT03703310","phase":"PHASE3","title":"Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Subjects With Basal Cell Nevus Syndrome (Gorlin Syndrome)","status":"COMPLETED","sponsor":"Sol-Gel Technologies, Ltd.","startDate":"2019-02-19","conditions":"Basal Cell Nevus Syndrome","enrollment":174},{"nctId":"NCT06108024","phase":"PHASE2","title":"A Trial to Evaluate the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic Keratosis","status":"RECRUITING","sponsor":"DermBiont, Inc.","startDate":"2023-11-06","conditions":"Seborrheic Keratosis","enrollment":60},{"nctId":"NCT03094403","phase":"PHASE1","title":"To Evaluate the Therapeutic Equivalence and Safety of Azelaic Acid 15% Topical Gel","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries, Inc.","startDate":"2016-07-01","conditions":"Rosacea","enrollment":1000},{"nctId":"NCT04078555","phase":"PHASE2","title":"A Study to Evaluate ENERGI-F703 GEL in Venous Leg Ulcer","status":"UNKNOWN","sponsor":"Energenesis Biomedical Co., Ltd.","startDate":"2022-07-26","conditions":"Venous Leg Ulcer","enrollment":80},{"nctId":"NCT05838170","phase":"PHASE2","title":"Study of TP-04 in Participants With Papulopustular Rosacea","status":"COMPLETED","sponsor":"Tarsus Pharmaceuticals, Inc.","startDate":"2023-03-01","conditions":"Papulopustular Rosacea","enrollment":37},{"nctId":"NCT05511948","phase":"PHASE2","title":"Randomized and Open Label Study for Safety and Efficacy of DBI-102 vs. Vehicle vs. Hydroquinone on Skin Pigmentation and Lentigos","status":"COMPLETED","sponsor":"DermBiont, Inc.","startDate":"2022-08-18","conditions":"Hyperpigmentation","enrollment":75},{"nctId":"NCT03998436","phase":"PHASE3","title":"Phase 3 Study to Evaluate the Safety and Efficacy of Galnobax® in Treating Diabetic Foot Ulcers","status":"COMPLETED","sponsor":"Novalead Pharma Private Limited","startDate":"2018-12-26","conditions":"Diabetic Foot Ulcer","enrollment":176},{"nctId":"NCT00031096","phase":"PHASE3","title":"Comparison of Efficacy and Safety of Azelaic Acid 15% Gel With Its Vehicle in Subjects With Mild to Moderate Acne","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2002-01","conditions":"Acne Vulgaris","enrollment":879},{"nctId":"NCT02242760","phase":"PHASE2","title":"P2 Multi-center Study of SB204 Gel in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Novan, Inc.","startDate":"2014-11","conditions":"Acne Vulgaris","enrollment":213},{"nctId":"NCT03436615","phase":"PHASE2","title":"A Study to Evaluate the Safety and Efficacy of SB206 in Subjects With Molluscum Contagiosum","status":"COMPLETED","sponsor":"Novan, Inc.","startDate":"2018-01-24","conditions":"Molluscum Contagiosum","enrollment":256},{"nctId":"NCT02462187","phase":"PHASE2","title":"Topical NVN1000 for the Treatment of External Genital and Perianal Warts","status":"COMPLETED","sponsor":"Novan, Inc.","startDate":"2015-06-12","conditions":"Genital Warts, Perianal Warts","enrollment":108},{"nctId":"NCT04769648","phase":"PHASE2, PHASE3","title":"Safety and Efficacy of Pro-ocular™ 1% in Daily Scleral Lens Wearing Patients With Ocular Graft-versus-Host Disease","status":"UNKNOWN","sponsor":"Glia, LLC","startDate":"2021-04-15","conditions":"Ocular Graft-versus-host Disease","enrollment":44},{"nctId":"NCT01659853","phase":"PHASE3","title":"Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of Rosacea","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2012-09","conditions":"Erythema, Rosacea","enrollment":70},{"nctId":"NCT04886739","phase":"PHASE2","title":"CGB-400 Topical Gel for the Treatment of Inflammatory Lesions of Rosacea","status":"COMPLETED","sponsor":"CAGE Bio Inc.","startDate":"2021-05-07","conditions":"Rosacea","enrollment":78},{"nctId":"NCT01138514","phase":"PHASE3","title":"Clinical Study Between Two Clindamycin 1%/Benzoyl Peroxide 5% Topical Gels","status":"COMPLETED","sponsor":"Padagis LLC","startDate":"2009-10","conditions":"Acne Vulgaris","enrollment":1555},{"nctId":"NCT03532776","phase":"PHASE3","title":"Comparison Between Podofilox Topical Gel 0.5% and Allergan's Condylox® Gel 0.5% for External Anogenital Warts","status":"COMPLETED","sponsor":"Dermax SA","startDate":"2018-04-20","conditions":"External Anogenital Warts","enrollment":466},{"nctId":"NCT03073486","phase":"PHASE3","title":"A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris","status":"COMPLETED","sponsor":"Dermira, Inc.","startDate":"2017-02-06","conditions":"Acne Vulgaris","enrollment":744},{"nctId":"NCT03028363","phase":"PHASE3","title":"A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris","status":"COMPLETED","sponsor":"Dermira, Inc.","startDate":"2016-12-27","conditions":"Acne Vulgaris","enrollment":759},{"nctId":"NCT02431052","phase":"PHASE2","title":"A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris","status":"COMPLETED","sponsor":"Dermira, Inc.","startDate":"2015-04","conditions":"Acne Vulgaris","enrollment":420},{"nctId":"NCT01936324","phase":"PHASE1, PHASE2","title":"A Safety, Tolerability and Preliminary Efficacy Study of DRM01B Topical Gel","status":"COMPLETED","sponsor":"Dermira, Inc.","startDate":"2013-08","conditions":"Acne Vulgaris","enrollment":114},{"nctId":"NCT01174030","phase":"PHASE2","title":"Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2010-08","conditions":"Rosacea","enrollment":269},{"nctId":"NCT01494467","phase":"PHASE3","title":"Phase 3 Papulopustular Rosacea Study","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2011-12","conditions":"Papulopustular Rosacea","enrollment":688},{"nctId":"NCT01493687","phase":"PHASE3","title":"Phase 3 Papulopustular Rosacea Study","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2011-12","conditions":"Papulopustular Rosacea (PPR)","enrollment":683},{"nctId":"NCT01106807","phase":"PHASE2","title":"Exploratory Study to Evaluate the Efficacy and Safety of CD07223 Gel in Subjects With Acne","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2010-04","conditions":"Acne","enrollment":73},{"nctId":"NCT02786901","phase":"PHASE3","title":"LE Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery","status":"COMPLETED","sponsor":"Bausch & Lomb Incorporated","startDate":"2016-06","conditions":"Cataract, Pain, Ocular Inflammation","enrollment":600},{"nctId":"NCT04163263","phase":"PHASE1","title":"Study to Evaluate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Effects of Repeat Topical Application of BOS-356 in Subjects With Moderate to Severe Acne Vulgaris","status":"COMPLETED","sponsor":"Boston Pharmaceuticals","startDate":"2019-11-04","conditions":"Moderate to Severe Acne Vulgaris","enrollment":66},{"nctId":"NCT04103060","phase":"PHASE2","title":"Safety and Tolerability Study of Cerdulatinib Gel, 0.37% in Adults With Vitiligo","status":"COMPLETED","sponsor":"Dermavant Sciences GmbH","startDate":"2019-09-27","conditions":"Vitiligo","enrollment":33},{"nctId":"NCT02208297","phase":"PHASE3","title":"Loteprednol Etabonate Ophthalmic Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery","status":"COMPLETED","sponsor":"Bausch & Lomb Incorporated","startDate":"2014-09","conditions":"Inflammation, Pain, Cataract","enrollment":326},{"nctId":"NCT01996839","phase":"PHASE3","title":"Loteprednol Ophthalmic Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery","status":"COMPLETED","sponsor":"Bausch & Lomb Incorporated","startDate":"2013-12","conditions":"Inflammation, Pain, Cataract","enrollment":514},{"nctId":"NCT03630939","phase":"PHASE1, PHASE2","title":"A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Topical ESR-114 in Subjects With Plaque Psoriasis","status":"COMPLETED","sponsor":"Escalier Biosciences B.V.","startDate":"2018-08-09","conditions":"Psoriatic Plaque","enrollment":104},{"nctId":"NCT02762084","phase":"PHASE2","title":"Trial of Patidegib Gel 2%, 4%, and Vehicle to Decrease the Number of Surgically Eligible Basal Cell Carcinomas in Gorlin Syndrome Patients","status":"COMPLETED","sponsor":"PellePharm, Inc.","startDate":"2016-06-06","conditions":"Basal Cell Nevus Syndrome","enrollment":17},{"nctId":"NCT01962987","phase":"PHASE3","title":"A Study Comparing Diclofenac Sodium Gel 3% to Solaraze® (Diclofenac Sodium) Gel 3% in the Treatment of Actinic Keratosis","status":"COMPLETED","sponsor":"Actavis Inc.","startDate":"2013-03","conditions":"Actinic Keratosis","enrollment":476},{"nctId":"NCT02120924","phase":"PHASE3","title":"A Study to Evaluate the Safety and Clinical Study of Azelaic Acid Gel 15% in Patients With Moderate Facial Rosacea","status":"COMPLETED","sponsor":"Actavis Inc.","startDate":"2013-07","conditions":"Rosacea","enrollment":1009},{"nctId":"NCT02710981","phase":"NA","title":"Sildenafil Vaginal Gel Co-treatment With Clomiphene Citrate in Infertile Women With Thin Endometrium","status":"COMPLETED","sponsor":"Assiut University","startDate":"2015-06","conditions":"Anovulation","enrollment":42},{"nctId":"NCT03727074","phase":"PHASE3","title":"Bioequivalence Study to Compare Sol-Gel Technologies' 5-FU Cream With Efudex® (5-FU) Cream","status":"COMPLETED","sponsor":"Sol-Gel Technologies, Ltd.","startDate":"2018-12-21","conditions":"Actinic Keratosis (AK)","enrollment":462},{"nctId":"NCT03859986","phase":"PHASE2","title":"Study in Subjects With Moderate Atopic Dermatitis","status":"UNKNOWN","sponsor":"Ralexar Therapeutics, Inc.","startDate":"2019-03-08","conditions":"Atopic Dermatitis Eczema","enrollment":124},{"nctId":"NCT01119898","phase":"PHASE2","title":"Exploratory Study of PENNSAID Gel to Treat Symptoms of Knee Osteoarthritis","status":"COMPLETED","sponsor":"Mallinckrodt","startDate":"2010-08-02","conditions":"Osteoarthritis of the Knee","enrollment":260},{"nctId":"NCT04134273","phase":"PHASE1","title":"Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries, Inc.","startDate":"2019-03-20","conditions":"Acne Vulgaris","enrollment":1260},{"nctId":"NCT03900676","phase":"PHASE2","title":"Efficacy and Safety Study of VB-1953 Topical Gel for Inflammatory Facial Acne Vulgaris","status":"UNKNOWN","sponsor":"Vyome Therapeutics Inc.","startDate":"2019-04-09","conditions":"Acne Vulgaris","enrollment":480},{"nctId":"NCT03688971","phase":"PHASE2","title":"Omiganan Twice a Day (BID) in Patients With Facial Seborrheic Dermatitis","status":"UNKNOWN","sponsor":"Maruho Co., Ltd.","startDate":"2018-10-22","conditions":"Seborrheic Dermatitis","enrollment":36},{"nctId":"NCT02828111","phase":"PHASE2","title":"Clinical Trial of Patidegib Gel 2%, 4%, and Vehicle Applied Once or Twice Daily to Decrease the GLI1 Biomarker in Sporadic Nodular Basal Cell Carcinomas","status":"COMPLETED","sponsor":"PellePharm, Inc.","startDate":"2016-11-11","conditions":"Basal Cell Carcinomas","enrollment":36},{"nctId":"NCT02709005","phase":"PHASE2","title":"Safety and Efficacy of 5% Monolaurin Vaginal Gel Administered Intravaginally for the Treatment of Bacterial Vaginosis","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2016-04-14","conditions":"Bacterial Vaginosis","enrollment":109},{"nctId":"NCT01844752","phase":"PHASE2","title":"A Phase 2, 3 Arm Study of NVN1000 Gel and Vehicle Gel in Subjects With Acne","status":"COMPLETED","sponsor":"Novan, Inc.","startDate":"2013-04","conditions":"Acne Vulgaris","enrollment":153},{"nctId":"NCT01844739","phase":"PHASE1","title":"A Phase 1 Study Evaluating Safety and Tolerability of NVN1000 Gel","status":"COMPLETED","sponsor":"Novan, Inc.","startDate":"2013-04","conditions":"Acne Vulgaris","enrollment":30},{"nctId":"NCT03175354","phase":"PHASE2","title":"A Study in Subjects With Moderate Atopic Dermatitis","status":"COMPLETED","sponsor":"Ralexar Therapeutics, Inc.","startDate":"2017-04-26","conditions":"Atopic Dermatitis, Eczema, Atopic","enrollment":209},{"nctId":"NCT03077750","phase":"PHASE2","title":"A Study of VBP-245 in Pediatric Patients With Molluscum Contagiosum","status":"COMPLETED","sponsor":"Veloce BioPharma LLC","startDate":"2017-02-27","conditions":"Molluscum Contagiosum","enrollment":110},{"nctId":"NCT02535104","phase":"PHASE1, PHASE2","title":"Safety and Efficacy Study of Topical Ranpirnase to Treat Genital Warts (HPV)","status":"COMPLETED","sponsor":"Tamir Biotechnology, Inc.","startDate":"2016-02","conditions":"Condylomata Acuminata, Papillomavirus Infections, Sexually Transmitted Diseases","enrollment":70},{"nctId":"NCT03003104","phase":"PHASE2","title":"DMT210 Topical Gel in the Treatment of Acne Rosacea","status":"COMPLETED","sponsor":"Dermata Therapeutics","startDate":"2017-01","conditions":"Acne Rosacea","enrollment":107},{"nctId":"NCT02949960","phase":"PHASE2","title":"DMT210 Topical Gel in the Treatment of Atopic Dermatitis","status":"COMPLETED","sponsor":"Dermata Therapeutics","startDate":"2016-10","conditions":"Atopic Dermatitis","enrollment":19},{"nctId":"NCT03351777","phase":"PHASE2","title":"Efficacy and Safety of PR022 Topical Gel to Treat Mild-to-Moderate Atopic Dermatitis","status":"UNKNOWN","sponsor":"Realm Therapeutics, Inc.","startDate":"2017-12-04","conditions":"Atopic Dermatitis","enrollment":120},{"nctId":"NCT02611804","phase":"PHASE3","title":"A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Multicenter Study Comparing Diclofenac Sodium Gel, 3% to Solaraze® Gel, 3% in the Treatment of Actinic Keratosis on the Face or Bald Scalp","status":"COMPLETED","sponsor":"Teva Pharmaceuticals USA","startDate":"2015-10","conditions":"Actinic Keratosis","enrollment":492},{"nctId":"NCT02595034","phase":"PHASE1","title":"A Study CLBG and Benzoyl Peroxide Gel 1%/5% to BenzaClin® Gel in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries, Inc.","startDate":"2015-01","conditions":"Acne Vulgaris","enrollment":1000},{"nctId":"NCT03132194","phase":"PHASE1","title":"Study Comparing Test to Aczone 7.5% and Both to a Placebo Control in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries, Inc.","startDate":"2016-08-08","conditions":"Acne Vulgaris","enrollment":1125},{"nctId":"NCT02929719","phase":"PHASE1","title":"Study Comparing Test to Aczone 5% and Both to a Placebo Control in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries, Inc.","startDate":"2014-04","conditions":"Acne Vulgaris","enrollment":1134},{"nctId":"NCT02173054","phase":"PHASE3","title":"An Efficiency of a Moisturizer Containing Licochalcone A, L-carnitine and 1,2-decanediol With Adapalene Gel in Acne","status":"COMPLETED","sponsor":"Mahidol University","startDate":"2014-07","conditions":"Acne","enrollment":120},{"nctId":"NCT02865005","phase":"PHASE3","title":"Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Seegpharm S.A.","startDate":"2016-02","conditions":"Acne Vulgaris","enrollment":2361},{"nctId":"NCT02677610","phase":"PHASE3","title":"Efficacy and Safety Study of MSRD-100 in Subjects With Atopic Dermatitis >=3 Months of Age and Older","status":"WITHDRAWN","sponsor":"Merz North America, Inc.","startDate":"","conditions":"Atopic Dermatitis","enrollment":""},{"nctId":"NCT02677636","phase":"PHASE3","title":"Efficacy and Safety Study of MSRD-100 in Subjects With Atopic Dermatitis >=3 Months of Age and Older","status":"WITHDRAWN","sponsor":"Merz North America, Inc.","startDate":"","conditions":"Atopic Dermatitis","enrollment":""},{"nctId":"NCT02395549","phase":"PHASE2","title":"A Study to Determine the Efficacy of Topically Applied MTC896 Gel in Subjects With Acne Vulgaris","status":"UNKNOWN","sponsor":"Mimetica Pty Limited","startDate":"2015-04","conditions":"Acne Vulgaris","enrollment":364},{"nctId":"NCT02421770","phase":"PHASE3","title":"Chamaemelum Nobile 2% Versus Placebo Topic Gel to Treat Oral Lichen Planus","status":"COMPLETED","sponsor":"Universidad de Murcia","startDate":"2014-01","conditions":"Oral Lichen Planus","enrollment":30},{"nctId":"NCT02164084","phase":"PHASE1","title":"A 2 Period Cross-over Pharmacokinetic Study of SB204 in Acne Vulgaris","status":"COMPLETED","sponsor":"Novan, Inc.","startDate":"2014-06","conditions":"Acne Vulgaris","enrollment":18},{"nctId":"NCT01670032","phase":"PHASE2, PHASE3","title":"Vehicle Controlled Efficacy and Safety Study of Two Dose Regimens of CD07223 1.5% Topical Gel in Impetigo","status":"COMPLETED","sponsor":"NovaBay Pharmaceuticals, Inc.","startDate":"2012-08","conditions":"Impetigo","enrollment":328},{"nctId":"NCT00840268","phase":"PHASE2","title":"A Study of Hydroxypropyl Guar Galactomannan 0.25% (HPGG) Versus Vehicle in Dry Eye Patients","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2009-02","conditions":"Dry Eye","enrollment":427},{"nctId":"NCT02052999","phase":"PHASE2","title":"Study to Evaluate the Efficacy and Safety of PAC-14028 Cream in Rosacea Patients","status":"COMPLETED","sponsor":"Amorepacific Corporation","startDate":"2013-02","conditions":"Erythematotelangiectatic Rosacea, Papulopustular Rosacea","enrollment":80},{"nctId":"NCT01742663","phase":"PHASE1","title":"A Study Comparing Diclofenac Sodium Gel 3% to Solaraze® Gel 3% in the Treatment of Actinic Keratosis","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries, Inc.","startDate":"2012-10","conditions":"Actinic Keratosis","enrollment":435},{"nctId":"NCT01467362","phase":"PHASE3","title":"Efficacy Emollient on Xerosis in Children With Atopic Dermatitis","status":"COMPLETED","sponsor":"Pierre Fabre Medicament","startDate":"2011-11","conditions":"Atopic Dermatitis","enrollment":251},{"nctId":"NCT01666509","phase":"NA","title":"Efficacy and Tolerability of Topical Rossoseq™ Compared to Vehicle in Rosacea Subtype 1 (Erythematotelangiectatic)","status":"COMPLETED","sponsor":"PBB Entrepreneur Ltd.","startDate":"2012-07","conditions":"Rosacea Subtype 1 (Erythematotelangiectatic)","enrollment":61},{"nctId":"NCT01265602","phase":"PHASE3","title":"Double-blind, Randomized, Vehicle- and Comparator-controlled, Multi-center Trial to Evaluate the Efficacy and Safety of LAS41007 in the Treatment of Actinic Keratosis","status":"COMPLETED","sponsor":"Almirall, S.A.","startDate":"2010-11","conditions":"Actinic Keratosis","enrollment":889},{"nctId":"NCT00573768","phase":"PHASE2","title":"Efficacy and Safety of Diclofenac Diethylamine 2.32% Gel in Patients With Acute Ankle Sprain","status":"COMPLETED","sponsor":"Novartis","startDate":"2007-11","conditions":"Ankle Sprain","enrollment":271},{"nctId":"NCT00151541","phase":"PHASE3","title":"A Phase 3 Study to Compare the Safety and Efficacy of 5% Dapsone Topical Gel, (DTG) Twice Daily in Combination With Once Daily Vehicle Control, Adapalene Gel 0.1% or Benzoyl Peroxide Gel 4%","status":"COMPLETED","sponsor":"Allergan","startDate":"2005-02","conditions":"Acne Vulgaris","enrollment":301},{"nctId":"NCT00621218","phase":"PHASE2","title":"A Study to Determine the Safety and Efficacy of Atralin (Tretinoin 0.05%) Gel for the Treatment of Rosacea","status":"COMPLETED","sponsor":"Coria Laboratories, Ltd.","startDate":"2008-02","conditions":"Rosacea","enrollment":36},{"nctId":"NCT00593177","phase":"PHASE2","title":"A Safety and Efficacy Study of a Topical Gel for the Treatment of Mild to Moderate Psoriasis","status":"COMPLETED","sponsor":"Manhattan Pharmaceuticals","startDate":"2007-10","conditions":"Psoriasis Vulgaris","enrollment":61},{"nctId":"NCT00661063","phase":"PHASE3","title":"Diabetic Neuropathy Topical Treatment","status":"UNKNOWN","sponsor":"Irmandade da Santa Casa de Misericordia de Sao Paulo","startDate":"2008-04","conditions":"Diabetic Neuropathy, Pain","enrollment":200}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Vehicle"],"phase":"phase_3","status":"active","brandName":"Vehicle Gel (BID)","genericName":"Vehicle Gel (BID)","companyName":"Bausch & Lomb Incorporated","companyId":"bausch-lomb-incorporated","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Vehicle Gel is a topical ophthalmic gel used to lubricate and protect the eyes. Used for Dry eye syndrome, Blepharitis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}